INTRODUCTION
Infections by multidrug-resistant (MDR) Gram-negative bacilli have become a major problem for patients in intensive care units throughout the world (Rossolini et al., 2007) .
During the last decade, there has been a resurgence in the use of old antibiotics, such as polymyxins, with improvements in dosing, different synergistic antimicrobial combinations and novel pharmaceutical formulations that have made it possible to reintroduce them into clinical practice (Falagas et al., 2010) . This was in response to the few therapeutic options that remain.
In Argentinian hospitals, a high number of Acinetobacter baumannii and Pseudomonas aeruginosa MDR strains are frequently isolated from nosocomial infections. For this reason, since 1998 the patients at several intensive care units have been treated with colistin for the management of infections caused by MDR strains (Rodríguez et al., 2004) .
A genetic mechanism that confers resistance to colistin in A. baumannii has recently been investigated (Adams et al., 2009; Beceiro et al., 2011) , whereas it is not well understood in members of the Enterobacteriaceae. Some reports have described in vivo selection of colistin resistance under colistin treatment in Klebsiella pneumoniae (Hrabák et al., 2011) as well as in A. baumannii (Hawley et al., 2008; Ló pez-Rojas et al., 2011) . Therefore, it is very important to investigate the features of these colistin-resistant isolates from different perspectives in order to define their clinical impact.
The aim of this study was to identify the contribution of the antibiotic resistance mechanisms associated with horizontal gene transfer present in colistin-resistant isolates of K. pneumoniae and A. baumannii. The epidemic or sporadic behaviour of the colistin-resistant isolates has also been investigated.
METHODS
Bacterial strains. Seventeen colistin-resistant non-epidemiologically related isolates of K. pneumoniae (n514) and A. baumannii (n53) recovered from three hospitals from Buenos Aires City during the period 2005-2009 were studied. Antimicrobial susceptibility. Antimicrobial resistance was tested by the antibiotic disc diffusion method and colistin susceptibility was tested by Etest and by the microdilution method following Clinical and Laboratory Standards Institute recommendations (CLSI, 2007 The gene cassette arrays in the variable region of class 1 integrons, the presence of Tn7, the presence of unusual class 1 integrons, the presence of bla OXA-48 and bla KPC-2 genes, the Etest MIC of colistin as well as the year of isolation, the hospital, the macrorestriction analysis of each strain (PFGE) and the prior use of colistin to treat each patient are shown. AMK, Amikacin; CEF, cefalotin; SXT, trimethoprim-sulfamethoxazole; CIP, ciprofloxacin; CTX, cefotaxime; CAZ, ceftazidime; MEM, meropenem; TZP, piperacillin-tazobactam; IPM, imipenem; R, resistant; S, susceptible; I, intermediate. (Quiroga et al., 2007) and PCR amplifications were carried out using the GoTaq enzyme according to the manufacturer's instructions (Promega). Several antimicrobial resistance determinants were searched for in each strain by PCR, and PCR cartography was performed as previously described (Post et al., 2010; Quiroga et al., 2007) . Sequencing of amplicons with ABI Prism 3100 BioAnalyser equipment and sequence analysis with BLAST V2.0 software (http:// www.ncbi.nlm.nih.gov/BLAST/) were performed (Orman et al., 2002; Quiroga et al., 2007) . To establish the clonal relationship between the colistin-resistant isolates, macrorestriction with ApaI for A. baumannii colistin-resistant isolates and with SpeI (Promega) for K. pneumoniae colistin-resistant isolates in a CHEF-DR III system (Bio-Rad) was performed as previously described (Barbolla et al., 2008) (Table 1) .
RESULTS AND DISCUSSION
A wide diversity of antimicrobial resistance mechanisms associated with horizontal gene transfer was found in 12 out of 14 K. pneumoniae colistin-resistant isolates ( Table 1) . The identified antimicrobial resistance determinants conferred resistance to different antibiotic families, including the carbapenemases bla KPC-2 or bla OXA-48 genes in four isolates (Table 1) . Eighty-six per cent of K. pneumoniae colistinresistant isolates harboured multiple class 1 integrons and 30 % possessed the Tn1331 transposon (Table 1 ). The complex class 1 integrons In35 : : ISCR1 : : bla CTX-M-2 , In132 : : ISCR1 : : bla CTX-M-2 , In131 : : ISCR1 : : qnrB10 and In37 : : ISCR1 : : bla CTX-M-2 were identified in 6 out of 14 K. pneumoniae colistin-resistant isolates. In addition, the presence of two complex class 1 integrons in the same isolate, Kp9, which is an infrequent event described in clinical isolates, was reported in this study (Table 1 ). The analysis by PFGE revealed that 11 clones of colistin-resistant K. pneumoniae are spreading in the three hospitals (Table 1) , evidence for independent acquisition of colistin resistance among K. pneumoniae isolates from our hospitals. Recently, in a hospital in the USA, transmission was reported of five cases of colistin-resistant K. pneumoniae isolates belonging to the international epidemic clone ST258 and harbouring bla KPC-2 (Bogdanovich et al., 2011) . Together, these results show that K. pneumoniae colistin-resistant clones with sporadic or epidemic behaviour that are circulating in nosocomial settings possess a genome plasticity that facilitates the acquisition of diverse antimicrobial resistance determinants usually associated with horizontal gene transfer.
A similar scenario to the epidemic behaviour of K. pneumoniae colistin-resistant ST258 was found when we analysed the three A. baumannii colistin-resistant isolates. We found by MLST that the A318, A319 and AF1 isolates belonged to ST131, which is also named clone 1 (data not shown). ST131 has been shown to have epidemic behaviour in nosocomial carbapenem-resistant A. baumannii isolates from Buenos Aires City since 1998 (Barbolla et al., 2008) and also from Brazil (Bogdanovich et al., 2011) . Class 1 and 2 integrons and also the bla OXA-23 carbapenemase gene were found in these isolates (Table 1 ). In addition, a genomic resistance island of the AbaR type, in which several antimicrobial determinants have been found (Post et al., 2010) , was identified in all isolates.
It was particularly worrying to find that pandrug-resistant isolates were identified in both species (A318, Kp4, Kp16, Kp18 and Kp31) ( Table 1 ). The accumulation of multiple genetic determinants in a single cell is contributing to the evolution towards pandrug resistance in both types of clones with either sporadic or epidemic behaviour. We do not know how these pandrug-resistant clones will change in the near future, but it is of particular concern that a continuous emergence of sporadic clones or the long-term maintenance of the epidemic clones in the nosocomial environment, or both, will occur, with their spread to patients in the community being one of the biggest worries.
